The Effect of Intravenous Tranexamic Acid in Percutaneous Renal Biopsy: A Single Center, Triple-blinded Randomized Controlled Trial
Not Applicable
- Conditions
- Any conditions that are the indication of percutaneous renal biopsy
- Registration Number
- JPRN-UMIN000019504
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Not provided
Exclusion Criteria
Exclusion criteria will be patients who are suspected of amyloidosis, who have any contraindication of tranexamic acid, who are pregnant or breast-feeding, who need tranexamic acid for treatment or who are thought not to be suitable to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Perirenal hematoma measured by using ultrasonography on the next morning after percutaneous renal biopsy
- Secondary Outcome Measures
Name Time Method